aripiprazole has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Araki, H; Kawasaki, H; Kohnomi, S; Suemaru, K | 1 |
1 review(s) available for aripiprazole and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
1 other study(ies) available for aripiprazole and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Behavior, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Models, Animal; Piperazines; Quinolones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine; Reflex, Startle; Serotonin Receptor Agonists; Stereotyped Behavior; Time Factors | 2008 |